Predicting Gastric Cancer Response to Chemo With Multimodal AI Model

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

February 1, 2013

Primary Completion Date

September 30, 2022

Study Completion Date

December 30, 2026

Conditions
Gastric CancerChemotherapy Effect
Interventions
DRUG

Neoadjuvant chemotherapy with radical tumor resection surgery

All patients were pathologically diagnosed as advanced gastric cancer, all receive neoadjuvant chemotherapy, after the completion of neoadjuvant chemotherapy, all patients receive radical tumor resection surgery (partial gastrectomy or total gastrectomy, as proper).

Trial Locations (1)

510655

RECRUITING

The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER

NCT06451393 - Predicting Gastric Cancer Response to Chemo With Multimodal AI Model | Biotech Hunter | Biotech Hunter